April 2026

The study first showed that in patients with atopic dermatitis, higher perceived stress was associated with worse disease severity and higher blood and skin eosinophil levels. In mice, repeated high-platform stress worsened dermatitis, increasing transepidermal water loss, scratching, dermal thickening, and eosinophil accumulation. Eosinophil depletion blunted this stress-driven worsening, showing that eosinophils were required. The authors then identified a distinct subset of prodynorphin-positive (Pdyn+) sympathetic 1 neurons that innervate hairy skin. Functional studies showed that Pdyn+ sympathetic neurons, but not neuropeptide Y-positive (Npy+) sympathetic neurons, were necessary and sufficient to drive stress aggravated dermatitis and eosinophilia. Mechanistically, these neurons recruited eosinophils through CCL11-CCR3 signaling and activated them through eosinophil Adrb2, promoting local inflammatory responses.

This is a significant paper because it moves beyond correlation and builds a causal neuroimmune circuit with several complementary approaches. The human cohort gives the work clinical relevance, while the mouse experiments provide mechanistic depth. Another strength is that the authors distinguish between sympathetic neuron subsets rather than treating the sympathetic nervous system as a single uniform stress pathway.

The main limitations are translational. The human data are retrospective and associative, and most of the mechanistic work is in mice. It also remains unclear whether the same circuit operates in human disease, whether it is specific to atopic dermatitis, and how it interacts with established type 2 inflammatory pathways already targeted in clinic.

Overall, this study pushes eosinophil biology into neuroimmunology. It argues that eosinophils are active participants in a defined stress-responsive circuit, not just downstream markers of inflamed skin. The next step is to test whether disrupting this neuro-eosinophil axis can reduce stress-related disease flares.